Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 95 Issue 4

If you are unable to see the message below, click here to view.

Advertisement Click here to download Myriad RBM's Neuroscience Application Notes. Learn how the continued identification and characterization of novel biomarker candidates for neurodegenerative, neuropsychiatric, and neuromuscular diseases promises to make significant contributions towards early detection and the development of therapeutic intervention. TABLE OF CONTENTS Volume 95, Issue 4 (April 2014) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development CPIC Update Regulation & Use State of the Art Review Research Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe In This Issue Top In This Issue Clin Pharmacol Ther 2014 95: 339; 10.1038/clpt.2014.31 Full Text Editorial Top A Snapshot of Challenges and Solutions in Cancer Drug Development and Therapy M A Phelps and A Sparreboom Clin Pharmacol Ther 2014 95: 341-346; 10.1038/clpt.2014.15 Abstract | Full Text News & Views Top HIGHLIGHTS Highlights Clin Pharmacol Ther 2014 95: 348-349; 10.1038/clpt.2014.30 Full Text ASCPT NEWS ASCPT News Clin Pharmacol Ther 2014 95: 350-353; 10.1038/clpt.2014.19 Full Text MACROSCOPY Herb–Drug Interactions in Oncology A K L Goey, J H Beijnen and J H M Schellens Clin Pharmacol Ther 2014 95: 354-355; 10.1038/clpt.2014.18 Full Text To Cap or Not to Cap: Chemotherapy Dosing in Obese Adult Hematology Patients G Sandhu, S Mapp, C Carrington and S Hennig Clin Pharmacol Ther 2014 95: 356-358; 10.1038/clpt.2014.3 Full Text Perspectives Top POINT/COUNTERPOINT The Scientific Basis of Body Surface Area–Based Dosing E Chatelut and F Puisset Clin Pharmacol Ther 2014 95: 359-361; 10.1038/clpt.2014.7 Full Text Conventional Dosing of Anticancer Agents: Precisely Wrong or Just Inaccurate? S Bins, M J Ratain and R H J Mathijssen Clin Pharmacol Ther 2014 95: 361-364; 10.1038/clpt.2014.12 Full Text OPINION “It’s the Economy, Stupid”: Strategies for Improved Cost Containment in Cancer Treatment S Sleijfer Clin Pharmacol Ther 2014 95: 365-367; 10.1038/clpt.2014.9 Abstract | Full Text COMMENTARY A Horizon-Prioritizing Method Can Identify Gaps Among Genomic Application Guidelines L Li Clin Pharmacol Ther 2014 95: 368-369; 10.1038/clpt.2014.16 Abstract | Full Text Discovery & Development Top DEVELOPMENT Pharmacotherapy in Cancer Patients With HIV/AIDS J H Beumer, R Venkataramanan and M A Rudek Clin Pharmacol Ther 2014 95: 370-372; advance online publication, January 17, 2014; 10.1038/clpt.2014.10 Abstract | Full Text Vasopressin Antagonists for Patients With Acute Heart Failure: Interpreting New Clinical and Translational Data A M Feldman, E Hamad, E J Tsai, W Zhu, D G Tilley, R Alvarez and J Y Cheung Clin Pharmacol Ther 2014 95: 373-375; advance online publication, December 17, 2013; 10.1038/clpt.2013.240 Full Text CPIC Update Top Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam, C A Prows, E D Kharasch and T C Skaar Clin Pharmacol Ther 2014 95: 376-382; advance online publication, January 23, 2014; 10.1038/clpt.2013.254 Abstract | Full Text Regulation & Use Top PRACTICE Pharmacogenetics in the Cancer Clinic: From Candidate Gene Studies to Next-Generation Sequencing H-J Guchelaar, H Gelderblom, T van der Straaten, JHM Schellens and JJ Swen Clin Pharmacol Ther 2014 95: 383-385; advance online publication, January 21, 2014; 10.1038/clpt.2014.13 Abstract | Full Text State of the Art Top Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials R Bruno, F Mercier and L Claret Clin Pharmacol Ther 2014 95: 386-393; advance online publication, January 13, 2014; 10.1038/clpt.2014.4 Abstract | Full Text Review Top Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method W D Dotson, M P Douglas, K Kolor, A C Stewart, M S Bowen, M Gwinn, A Wulf, H M Anders, C Q Chang, M Clyne, T K Lam, S D Schully, M Marrone, W G Feero and M J Khoury Clin Pharmacol Ther 2014 95: 394-402; advance online publication, February 19, 2014; 10.1038/clpt.2013.226 Abstract | Full Text Race and Ethnicity in Cancer Therapy: What Have We Learned? C Grenade, M A Phelps and M A Villalona-Calero Clin Pharmacol Ther 2014 95: 403-412; advance online publication, January 13, 2014; 10.1038/clpt.2014.5 Abstract | Full Text Adaptive Reprogramming of the Breast Cancer Kinome T J Stuhlmiller, H S Earp and G L Johnson Clin Pharmacol Ther 2014 95: 413-415; advance online publication, January 10, 2014; 10.1038/clpt.2014.8 Abstract | Full Text Research Top ARTICLES Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance A N Werk, S Lefeldt, H Bruckmueller, G Hemmrich-Stanisak, A Franke, M Roos, C Küchle, D Steubl, C Schmaderer, J H Bräsen, U Heemann, I Cascorbi and L Renders Clin Pharmacol Ther 2014 95: 416-422; advance online publication, October 14, 2013; 10.1038/clpt.2013.210 Abstract | Full Text Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing SL Van Driest, Y Shi, EA Bowton, JS Schildcrout, JF Peterson, J Pulley, JC Denny and DM Roden Clin Pharmacol Ther 2014 95: 423-431; advance online publication, November 19, 2013; 10.1038/clpt.2013.229 Abstract | Full Text Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects S Misaka, J Yatabe, F Müller, K Takano, K Kawabe, H Glaeser, M S Yatabe, S Onoue, J P Werba, H Watanabe, S Yamada, M F Fromm and J Kimura Clin Pharmacol Ther 2014 95: 432-438; advance online publication, January 13, 2014; 10.1038/clpt.2013.241 Abstract | Full Text Cutaneous Iontophoresis of Treprostinil in Systemic Sclerosis: A Proof-of-Concept Study M Roustit, F Gaillard-Bigot, S Blaise, F Stanke-Labesque, C Cracowski, C Seinturier, J-F Jourdil, B Imbert, P H Carpentier and J-L Cracowski Clin Pharmacol Ther 2014 95: 439-445; advance online publication, January 23, 2014; 10.1038/clpt.2013.255 Abstract | Full Text Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients With Non–Small Cell Lung Cancer Based on MONET1 Study Results L Claret, R Bruno, J-F Lu, Y-N Sun and C-P Hsu Clin Pharmacol Ther 2014 95: 446-451; advance online publication, January 17, 2014; 10.1038/clpt.2014.11 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.